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Abstract
The bronchopneumonia of calves represents a risk to national supply chain because it is an ecopathy and weakens 
the more intensive production systems. It is characterized by inflammatory changes in the bronchi, bronchioles, lung 
parenchyma, and pleura. It is a disease of multifactorial traits called Bovine Respiratory Disease (BRD). The association 
of infectious agents with host defense and management to which the animal is subjected leads to the emergence of 
major clinical manifestations of the disease. The clinical evolution of BRD can also have serious secondary changes 
such as pulmonary edema, sepsis, and pulmonary hypertension, or even be consequent to the involvement of other 
structures, such as in cases of myocarditis leading to congestive heart failure. Although this report refers to a non-
experimental framework, the circumstances that caused the calf to be subjected to a protocol-specific respiratory 
assessment involving non-routine reviews have made it possible to associate circulatory and respiratory conditions, 
rarely considered in ruminant clinics. The focus of this report was pulmonary edema. Modern clinical vision requires 
work with cost-benefit relation by the veterinarian, and the more accurate and the earlier the clinical diagnosis the less 
expensive the treatment.
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Resumo
A broncopneumonia dos bezerros representa um risco à cadeia produtiva nacional por ser uma ecopatia e por fragilizar 
os sistemas de produção mais intensivos. É caracterizada por alterações inflamatórias de brônquios, bronquíolos, 
parênquima pulmonar e pleura. Por ser uma doença de características multifatoriais, é denominada Complexo Doença 
Respiratória de Bovinos (CDRB). A interação dos agentes infecciosos, a defesa do hospedeiro e o manejo ao qual o 
animal é submetido determinam as principais manifestações clínicas da doença. A evolução clínica do CDRB também 
pode apresentar alterações secundárias graves como o edema pulmonar, a septicemia e a hipertensão pulmonar, 
ou mesmo ser consequente ao comprometimento de outras estruturas, como nos casos de miocardite que levam à 
insuficiência cardíaca congestiva. Apesar de este relato referir-se a um quadro não experimental, as circunstâncias 
de submissão a um protocolo de avaliação respiratória específico, envolvendo avaliações não rotineiras, permitiram 
associar as interações circulatórias e o quadro respiratório, algo pouco considerado em clínicas de ruminantes. O foco 
deste relato foi o edema pulmonar. A visão clínica moderna obriga o médico veterinário a trabalhar a relação custo-
benefício, e quanto mais acurado e precoce é o diagnóstico clínico, menos dispendioso é o tratamento.
Palavras-chave: Broncopneumonia. Edema pulmonar. Septicemia. Miocardite. Bovinos. Prognóstico. Tratamento.
In Brazil as in other countries where cattle farming 
is significant higher calf mortality rates are recorded 
during the first month of life (BENESI, 1993), and 
bronchopneumonia is considered a very important 
problem, reaching 12.7% of calves raised in extensive 
system and constituting between 13% and 23.9% of the 
diseases that affect calves under one year of age (RABELO 
et al., 1996). Despite being a common disease, there is a 
different prognosis and the establishment of this is crucial 
for the design of the damage caused by this important 
nosological complex. The main research on the subject 
describes economic losses arising from the impairment 
of development (BLUM et al., 1996), mortality, infectious 
aspects, and risk factors (COUTINHO, 2004).
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However, the clinical course of Bovine Respiratory 
Disease (BRD), especially bronchopneumonic, may 
present serious secondary changes such as pulmonary 
edema (MORLÁN, 2003), sepsis, and pulmonary 
hypertension, or even be consequence of the involvement 
of other structures, such as in cases of myocarditis 
(MCGAVIN; ZACHARY, 2009), which requires formation 
of the clinic and allows different expectations.
In this paper, the interactions that can compromise the 
patient’s prognosis will be discussed and presented in the 
form of highly complex respiratory changes.
This report refers to a bovine male Holstein, three 
months old, with historic of prostration, lack of appetite, 
dyspnea, and fever for about two hours. It was an 
animal subjected to adequate colostration, confirmed by 
determining total serum protein proven by refractometry. 
The same had been followed clinically by daily general 
physical examination. No changes had been found so far 
to justify such manifestations.
Upon physical examination the animal was 
lethargic in sternal recumbency, presented tachycardia 
(HR = 128 bpm), tachypnea (RR = 80 mpm), fever 
(T °C = 40,8 °C), and palpebral conjunctiva were flushed. 
In the specific examination of the respiratory system, on 
palpation the cough reflex was negative, and dullness to 
percussion and auscultation to rattle wet were identified. 
Endoscopic examination of the airways was performed 
because the episode had occurred after feeding and there 
was suspicion of obstruction. This fact was not confirmed, 
as evidenced pulmonary edema by the amount of foamy 
translucent content in the trachea and main bronchi, as 
well as respiratory acidosis, which was confirmed by blood 
gas analysis (Table 1).
Table 1 –  Results of laboratory test (hemogasometry) made 
on the first day of service of a calf with respiratory 
changes – São Paulo, 2013
Day 01 Reference value*
pH 7,28 7,31 – 7,53
pO2 (mmHg) 21,8 > 85
pCO2 (mmHg) 67,7 35 – 44
HCO3- (mEq/L) 31,7 17 – 29
Osmolality (mOsm/kg) 253,5 270 – 300
Anion gap (mmol/L) 12,6 14 – 20
* Smith (2006)
In the case of an acute and emergency framework, 
the protocol was instituted furosemide (2.0 mg/kg), 
dexamethasone (single dose of 0.3 mg/kg), dipyrone 
(25 mg/kg), and enrofloxacin (5.0 mg/kg). The animal was 
also submitted to oxygen therapy for two hours with a PO2 
arterial of 59 mmHg.
The result was immediate, heart and respiratory rate 
normalized, as well as the temperature of 40,8 ºC regressed 
to 39,4 ºC. Subsequent daily monitoring of the animal 
showed an improvement of clinical signs presented. 
Furosemide and dexamethasone were maintained for 
two days and seven days of enrofloxacin, with apparent 
remission.
After 25 days of the diagnosis of pulmonary edema, the 
animal expressed a critical episode similar to the above. 
Blood count, biochemistry, and blood gas analysis were 
requested. The same treatment was carried out but with 
the substitution of enrofloxacin for ceftiofur (2.2 mg/kg) 
and the addition of aminophylline (6.0 mg/kg).
Based on clinical symptoms, history, and physical 
and laboratory tests, there was suspicion of a disease 
in the circulatory system to justify the recurrent 
respiratory changes. Therefore, three tests were required: 
echocardiography, measurement of cardiac troponin I, and 
measurement of ECG by Holter. In the echocardiography 
a decrease in ventricular contractility the value of cardiac 
troponin I was observed, higher (0.07 ng/mL) when 
compared to a healthy calf; the ECG by Holter showed 
no changes.
The animal was not responsive to treatment in the 
second episode, coming to death seven days later. In the 
macroscopic findings of the autopsy, pulmonary congestion 
was observed, with the presence of plaques of fibrinous 
exudate, also present in the trachea, as well as a foamy 
content. In other organs there was no noticeable changes 
of note.
The first clinical evidence shows pulmonary edema. 
At the time, the picture presented sudden onset and was 
admitted to the animal actually being systematically 
subjected to physical examination, specific examination 
of the respiratory system, complete with blood tests and 
endoscopic airway for healthy animal image registration.
At diagnosis of edema, it also had increased temperature, 
as described in cases of acute pulmonary edema (WILSON; 
LOFSTEDT, 1990; GONÇALVES et al., 2001).
The consequences of an inflammatory process 
along the feverish process led to the animal prostration 
(LIVINGSTON, 2000; HAZEWINKEL et al., 2008).
The framework required emergency measures that 
have been adopted, and treatment was established 
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according to many authors (HAWKINS, 1997; 
NELSON;  COUTO,  2006). The principles of therapy 
include pulmonary edema reduction activity, the patency 
of the air passages, reduction in alveolar hypoxia, improved 
blood oxygenation and tissues, and the correction of acid-
base imbalances.
Furosemide at dose of 2.0 mg/kg provided comfort to the 
animal every time it was administered. According to Nelson 
and Couto (2006), diuretics are quite effective in relieving 
pulmonary edema in the early stages, but this effect tends 
to decrease with the progression of the cause of the edema. 
Furosemide and its loop diuretic effect reduces afterload and 
improves left ventricular emptying, reducing pulmonary 
congestion and decreasing myocardial oxygen consumption.
The oxigenotherapy held in two stages improved the 
breathing capacity of the animal. Nelson and Couto (2006) 
state that it is suitable for all patients with signal of 
respiratory distress.
The dipyrone was administered at a dose of 25 mg/kg 
intravenously or intramuscularly every time the animal 
had fever – depending on how high the temperature and 
the clinical condition of the animal was. Within three 
to four hours the temperature decreased considerably. 
Kallmünzer et al. (2011) intervened in 331 cases of fever 
with the sequential administration of paracetamol and 
dipyrone, which resulted in a significant drop in body 
temperature of calves after 60 minutes.
There are no reports of corticosteroids indicated for the 
treatment of pulmonary edema. Nevertheless, knowing the 
action of corticosteroids and since the animal had already 
been diagnosed with bronchopneumonia, the drug was 
administered at the dose of 0.3 mg/kg in three different 
episodes. After intravenous administration, there was clear 
symptomatic improvement, primarily through appetite 
and attitude.
The radiographic examination was not performed due 
to remission of symptoms and also of a portable device at 
that time, since it would be impracticable to take the animal 
to the radiology block due to stress.
After 25 days the animal had a second episode of 
edema, demonstrating a greater lung commitment. Firstly, 
we carried out the exchange of the ceftiofur antibiotic for 
the dose of 2.2 mg/kg every 24 hours for six days, believing 
in the resistance of the bacterial agent to the previously 
administered antibiotic. The ceftiofur hydrochloride is an 
antibiotic from the class of third generation cephalosporins 
having a broad spectrum of action.
Aminophylline was added to the treatment at a dosage of 
6.0 mg/kg, which according to the authors Hawkins (1997) 
and Morlán (2003) is a bronchodilator – methylxanthine, 
which has positive inotropic, diuretic, and bronchodilatory 
properties, and increases diaphragmatic contraction.
Nonsteroidal anti-inflammatory (flunixin meglumine), 
bronchodilators (broxemina hydrochloride), and fluid, 
as well as lactated Ringer’s saline were added to maintain 
the treatment of the animal (CARDOSO et al.,  2002; 
COUTINHO, 2004), but it was not successful.
Echocardiography provides information about the 
anatomical variations, endocardial lesions, congenital 
anomalies, tumors, and pericardial disease. This is 
indicated for animals with genetic value, which show 
signs of heart disease for which one cannot reach a specific 
diagnosis (PEEK; MCGUIRK, 2008). In the animal in 
question a decrease in cardiac contractility and vitality 
of low strength ventricular contraction was observed, 
similar to what Mendes et al. (1994) described in frames 
of myocarditis. Nevertheless, expansion of the chambers, 
mitral and tricuspid insufficiency, pericardial effusion, and 
intracardiac thrombosis were not found.
Echocardiographic evaluations in ruminants are 
restricted and Michima (2007), which described the 
echocardiographic evaluation technique for calves and 
said characteristics of evaluations of cardiac calves cameras 
providing this information to clinical use. In 2010, Pogliani 
used this resource for cardiac evaluation in cloned calves 
derived from nuclear transfer from adult somatic cells, 
and this study relates to the respiratory condition in calf 
Holstein with three months of age. Following the evaluation 
criteria proposed by Michima (2007) and Pogliani (2010) 
no changes were identified.
O’Brien (2008) states that there are no specific biomarkers 
for the diagnosis of myocarditis in bovine medicine. 
Although creatine kinase, lactate dehydrogenase, and its 
isoenzymes in human and animals are used for the detection 
of myocardial damage, the effective use of these enzymes is 
limited due to the lack of tissue specificity and sensitivity.
Many authors (ALPERT et al., 2000; O’BRIEN, 2008) 
report that the best cardiac biomarker for myocardial 
damage is the determination of cardiac troponin 
concentration (cTnI and cTnT), because they have 
specificity almost completely by the myocardial tissue and 
greater sensitivity than other biomarkers. According to 
the American College of Cardiology and The European 
Society of Cardiology, troponin is regarded as a preferred 
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biomarker for infarction (ALPERT et al., 2000) and has 
become the subject of research in veterinary medicine 
in recent years. Some assays have been developed in 
several animal species for determination of human 
troponin (OYAMA;  SISSON,  2004; MICHIMA, 2007; 
LEONARDI et al., 2008), while bovine cardiac troponin 
can be used as a biomarker for heart disease in cattle 
(KARAPINAR et al., 2010).
This study was performed with cTnI measurement 
yielding a value of 0.07 ng/ml. It was considered the high 
value when compared to the result of a healthy calf, which 
was 0.00 ng/mL. Similar to this result, Varga et al. (2013) 
conducted research on cTnI cows with various diseases, 
including pneumonia observed that the median value 
for cTnI was 0.03 ng/ml and the maximum value of 
0.05 ng/ml, while in healthy animals this value did not 
exceed 0.02 ng/ml.
Likewise, the increase in cTnI has been 
identified in people with heart diseases like sepsis 
(DE GENNARO et al., 2008; TSAI et al., 2008) and septic 
shock (DE GENNARO et al., 2008; LAZZERI et al., 2008), 
embolism (MARGATO et al., 2009), and chronic obstructive 
pulmonary disease (FRUCHTER; YIGLA, 2009). Similar 
findings have been reported in foals with septicemia 
(SLACK et al., 2005) and calves with experimentally 
induced endotoxemia (PEEK; MCGUIRK, 2008).
From the assessment of these works with the current 
one, it may be inferred that the dosage of cTnI is important 
not only to investigate the extent of primary cardiac lesions, 
but also as a useful tool in the search for the presence of 
secondary cardiac complications or vice versa.
As for the Holter method adopted for the evaluation, 
standardized criteria for dogs (MAZINI, 2011) was used, 
since there are no descriptions for ruminants, currently in 
the process of standardization.
From these tests it was possible to prove a myocardial 
dysfunction in the context, but it was not possible to say 
if it was primary or secondary. Since it may have caused 
pulmonary edema framework, which led to a weakness 
of this body causing pneumonia, and for being a shock 
organ led to sepsis, or pneumonia caused sepsis leading 
to a myocardium dysfunction.
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